DRUG TRANSPORT IN BRAIN

大脑中的药物转运

基本信息

项目摘要

Theoretical transport models of high-flow microinfusion into brain tissue have been developed, treating the brain as either a rigid or a deformable elastic medium into which macromolecular solutions are infused at flow rates from 0.1 to 6.0 ~l/min. Previous work has shown that this technique allows slowly degraded macromolecules to access treatment volumes in the range of at least 14 to 27 cu cm. These computations have been extended to describe more reactive molecules, such as neuropeptides and growth factors. Penetration depths and associated treatment volumes based on pharmacodynamic effect have been calculated and shown to be strongly dependent on metabolic rate. Treatment volumes are expected, respectively, to be 2.7 cu cm (1.7 cm dia.) and 0.5 cu cm (0.98 cm dia.) for substances of 1-hr (e.g., a chimeric neuropeptide) and 10-min (e.g., a growth factor) reaction times. Such substances achieve infusion steady-state concentration profiles over 0.5-hr to 3-hr infusions and, unlike unreactive macromolecules, possess sigmoidal profiles that lack a precipitous front. Although the greater reactivity of these agents reduces expected tissue penetration, it does not alter the relative advantage that high-flow microinfusion of these agents provides over competing low-flow or polymer-dissolution methods. In other experimental work, we have confirmed the prediction that the slowly clearing macromolecule albumin is transported spherically outward in grey matter with a moving front profile until it encounters a grey-white boundary.
高流量微量输注脑组织的理论输运模型

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

P F MORRISON其他文献

P F MORRISON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('P F MORRISON', 18)}}的其他基金

THYMIDYLATE SYNTHASE REGULATION
胸苷酸合酶调节
  • 批准号:
    5204103
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
KINETICS OF FOLATE METABOLISM
叶酸代谢动力学
  • 批准号:
    3852950
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
THYMIDYLATE SYNTHASE REGULATION
胸苷酸合酶调节
  • 批准号:
    3789467
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
SULFONE STRUCTURE-ACTIVITY ANALYSIS
砜结构-活性分析
  • 批准号:
    3916238
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
DRUG TRANSPORT IN BRAIN
大脑中的药物转运
  • 批准号:
    2590318
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
SOURCES OF QUINOLINIC ACID
喹啉酸的来源
  • 批准号:
    2449928
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
KINETICS OF FOLATE METABOLISM
叶酸代谢动力学
  • 批准号:
    3937317
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
THYMIDYLATE SYNTHASE REGULATION
胸苷酸合酶调节
  • 批准号:
    3767486
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
KINETICS OF FOLATE METABOLISM
叶酸代谢动力学
  • 批准号:
    3874202
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
SOURCES OF QUINOLINIC ACID
喹啉酸的来源
  • 批准号:
    6163213
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
  • 批准号:
    10685312
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
  • 批准号:
    10490872
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts
利用和增强花生和坚果 2S 白蛋白的 IgE 结合表位
  • 批准号:
    10345963
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Development of Highly Functionalized Serum Albumins as Boron Delivery Carries to Tumor for Neutron Capture Therapy
开发高功能化血清白蛋白作为硼输送至肿瘤以进行中子捕获治疗
  • 批准号:
    17H02202
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Studies on Asymmetric Nitroaldol Reaction using mutant albumins
突变体白蛋白不对称硝醛醇反应的研究
  • 批准号:
    16K05706
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SPIN LABELING STUDIES OF NORMAL RECOMBINANT & MUTANT HUMAN SERUM ALBUMINS
正常重组的旋转标记研究
  • 批准号:
    6118869
  • 财政年份:
    1999
  • 资助金额:
    --
  • 项目类别:
COPPER BINDING OF COMMERCIAL, NORMAL RECOMBINANT, & MUTANT HUMAN SERUM ALBUMINS
商业、正常重组的铜结合,
  • 批准号:
    6118864
  • 财政年份:
    1999
  • 资助金额:
    --
  • 项目类别:
Structure and Metabolism of the Serum Albumins Characteristic of Bisalbuminemia in Fowl
家禽双清蛋白血症血清白蛋白的结构与代谢特征
  • 批准号:
    67B6472
  • 财政年份:
    1967
  • 资助金额:
    --
  • 项目类别:
Structure and Metabolism of the Serum Albumins Characteristic of Bisalbuminemia
双清蛋白血症血清白蛋白的结构和代谢特征
  • 批准号:
    65B3344
  • 财政年份:
    1965
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了